Harris B. Therapeutic work and mental illness in America, c. 1830–1970. In: Ernst W, editor. Work, psychiatry and society c. 1750–2015. Manchester: Manchester University Press; 2016.
Ross DR, Lewin R, Gold K, Ghuman HS, Rosenblum B, Salzberg S, et al. The psychiatric uses of cold wet sheet packs. Am J Psychiatry. 1988;145:242–5.
Whitrow M. Wagner-Jauregg and fever therapy. Med Hist. 1990;34:294–310.
Kalinowsky LB. History of convulsive therapy. Ann N Y Acad Sci. 1986;462:1–4.
Jasper HH. A historical perspective. The rise and fall of prefrontal lobotomy. Adv Neurol. 1995;66:97–114.
Freeman W. Frontal lobotomy 1936-1956: a follow-up study of 3000 patients from one to twenty years. Am J Psychiatry. 1957;113:877–86.
Wing JK. Five-year outcome in early schizophrenia. Proc Royal Soc Med. 1966;59:17–8.
Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812.
Grossman LS, Harrow M, Rosen C, Faull R, Strauss GP. Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry. 2008;49:523–9.
Grob GN. From asylum to community: mental health policy in modern America. Princeton: Princeton University Press; 2014.
Kirkpatrick H, Byrne C. A narrative inquiry: moving on from homelessness for individuals with a major mental illness. J Psychiatr Ment Health Nurs. 2009;16:68–75.
Caton CLM. The open door: homelessness and severe mental illness in the era of community treatment. Oxford: Oxford University Press; 2017.
Ran MS, Mao WJ, Chan CL, Chen EY, Conwell Y. Gender differences in outcomes in people with schizophrenia in rural China: 14-year follow-up study. Br J Psychiatry. 2015;206:283–8.
Thorup A, Albert N, Bertelsen M, Petersen L, Jeppesen P, Le Quack P, et al. Gender differences in first-episode psychosis at 5-year follow-up--two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry. 2014;29:44–51.
Greve J, Herrup Nielsen L. Useful beautiful minds—an analysis of the relationship between schizophrenia and employment. J Health Econ. 2013;32:1066–76.
Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–42.
Chatterji P, Alegria M, Takeuchi D. Psychiatric disorders and labor market outcomes: evidence from the National Comorbidity Survey-Replication. J Health Econ. 2011;30:858–68.
Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM. Sex differences in the course of schizophrenia across diverse regions of the world. Neuropsychiatr Dis Treat. 2016;12:2927–39.
Drake RE, Bond GR, Thornicroft G, Knapp M, Goldman HH. Mental health disability: an international perspective. J Disab Policy Stud. 2012;23:110–20.
Ran MS, Wong YI, Yang SY, Ho PS, Mao WJ, Li J, et al. Marriage and outcomes of people with schizophrenia in rural China: 14-year follow-up study. Schizophr Res. 2017;182:49–54.
Thara R, Kamath S. Women and schizophrenia. Indian J Psychiatry. 2015;57:S246–51.
Reupert A, Maybery D, Cox M, Scott Stokes E. Place of family in recovery models for those with a mental illness. Int J Ment Health Nurs. 2015;24:495–506.
Yu MY, Shim W. Couples with schizophrenia “becoming like others” in South Korea: marriage as part of a recovery process. Fam Process. 2009;48:429–40.
Khalifeh H, Moran P, Borschmann R, Dean K, Hart C, Hogg J, et al. Domestic and sexual violence against patients with severe mental illness. Psychol Med. 2015;45:875–86.
Jonas S, Khalifeh H, Bebbington PE, McManus S, Brugha T, Meltzer H, et al. Gender differences in intimate partner violence and psychiatric disorders in England: results from the 2007 adult psychiatric morbidity survey. Epidemiol Psychiatr Sci. 2014;23:189–99.
Seeman MV. Bad, burdened or ill? Characterizing the spouses of women with schizophrenia. Int J Soc Psychiatry. 2013;59:805–10.
Trevillion K, Oram S, Feder G, Howard LM. Experiences of domestic violence and mental disorders: a systematic review and meta-analysis. PLoS One. 2012;7:e51740.
Frayne J, Brooks J, Nguyen TN, Allen S, Maclean M, Fisher J. Characteristics of men accompanying their partners to a specialist antenatal clinic for women with severe mental illness. Asian J Psychiatr. 2014;7:46–51.
Ranning A, Laursen TM, Thorup A, Hjorthøj C, Nordentoft M. Children of parents with serious mental illness: with whom do they grow up? A prospective, population-based study. J Am Acad Child Adolesc Psychiatry. 2016;55:953–61.
Fazel S, Wolf A, Palm C, Lichtenstein P. Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden. Lancet Psychiatry. 2014;1:44–54.
Ranning A, Laursen TM, Thorup A, Hjorthøj C, Nordentoft M. Serious mental illness and disrupted caregiving for children: a nationwide, register-based cohort study. J Clin Psychiatry. 2015;76:1006–14.
Seeman MV. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treat. 2012;2012:796763.
Seeman MV. Parenting issues in mothers with schizophrenia. Curr Womens Health Rev. 2010;6:51–7.
Drake RE, McHugo GJ, Xie H, Fox M, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull. 2006;32:464–73.
Drake RE, Luciano AE, Mueser KT, Covell NH, Essock SM, Xie H, et al. Longitudinal course of clients with co-occurring schizophrenia-spectrum and substance use disorders in urban mental health centers: a 7-year prospective study. Schizophr Bull. 2016;42:202–11.
Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res. 2008;100:242–51.
Wojtalik JA, Barch DM. An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia. Front Psych. 2014;5:1.
Wong QJ, Miller M. Broad spectrum psychiatric comorbidity is associated with better executive functioning in an inpatient sample of individuals with schizophrenia. Compr Psychiatry. 2015;60:47–52.
Potvin S, Stavro K, Pelletier J. Paradoxical cognitive capacities in dual diagnosis schizophrenia: the quest for explanatory factors. J Dual Diagn. 2012;8:35–47.
Buccelli C, Della Casa E, Paternoster M, Niola M, Pieri M. Gender differences in drug abuse in the forensic toxicological approach. Forensic Sci Int. 2016;265:89–95.
Keyes KM, Martins SS, Bianco C, Hasin DS. Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry. 2010;167:969–76.
Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2009;66:152–61.
Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009;6:e1000120.
Reitan SK, Helvik A-S, Iversen V. Use of mechanical and pharmacological restraint over an eight-year period and its relation to clinical factors. Nord J Psychiatry. 2018;72:24–30.
Beck NC, Durrett C, Stinson J, Coleman J, Stuve P, Menditto A. Trajectories of seclusion and restraint at a state psychiatric hospital. Psychiatr Serv. 2008;59:1027–32.
Nawka A, Kalisova L, Raboch J, Giacco D, Cihal L, Onchev G, et al. Gender differences in coerced patients with schizophrenia. BMC Psychiatry. 2013;13:257.
Keski-Valkama A, Sailas E, Eronen M, Koivisto AM, Lönnqvist J, Kaltiala-Heino R. Who are the restrained and secluded patients: a 15-year nationwide study. Soc Psychiatry Psychiatr Epidemiol. 2010;45:1087–93.
Popovic D, Benabarre A, Crespo JM, Goikolea JM, González-Pinto A, Gutiérrez-Rojas L, et al. Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014;130:418–26.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P. Suicide in schizophrenia. Expert Rev Neurother. 2010;10:1153–64.
Fuller-Thomson E, Hollister B. Schizophrenia and suicide attempts: findings from a representative community-based Canadian sample. Schizophr Res Treat. 2016;2016:1–11 3165243.
Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010;24:S81–90.
Kiviniemi M. Mortality, disability, psychiatric treatment and medication in first-onset schizophrenia in Finland: the register linkage study. Acta Univ Oulu. 2014:D 1267 http://jultika.oulu.fi/files/isbn9789526206325.pdf. Accessed 19 Nov 2018.
Austad G, Joa I, Johannessen JO, Larsen TK. Gender differences in suicidal behaviour in patients with first-episode psychosis. Early Interv Psychiatry. 2015;9:300–17.
Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A, Castle DJ. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey. J Affect Disord. 2015;172:30–7.
Large M, Smith G, Sharma S, Nielssen O, Singh SP. Systematic review and meta-analysis of the clinical factors associated with the suicide of psychiatric in-patients. Acta Psychiatr Scand. 2011;124:18–29.
De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52–77.
Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat. 2015;72:1172–81.
Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241:211–8.
Bai YM, Su TP, Chen MH, Chen TJ, Chang WH. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study. J Affect Disord. 2013;150:57–62.
Crump C, Sunquist K, Winkleby MA, Sundquist J. Mental disorders and risk of accidental death. Br J Psychiatry. 2013;203:297–302.
Yuen K, Harrigan SM, Mackinnon AJ, Harris MG, Yuen HP, Henry LP, et al. Long-term follow-up of all-cause and unnatural death in young people with first-episode psychosis. Schizophr Res. 2014;159:70–5.
Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131:101–4.
Lee EE, Liu J, Tu LX, Palmer BW, Eyler LT, Jeste DV. A widening longevity gap between people with schizophrenia and general population: a literature review and call for action. Schizophr Res. 2018;196:9–13.
Gøtzsche PC, Young AH, Crace J. Does long term use of psychiatric drugs cause more harm than good? BMJ. 2015;350:h2435.
Taipale H, Mittendorfer-Rutza E, Alexanderson K, Majak M, Mehtälä J, Hoti F, et al. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res. 2018;197:274–80.
Zhou J, Xiang YT, Li Q, Zhu X, Li W, Ungvari GS, et al. Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia. Psychiatry Res. 2016;245:276–81.
Fadiran EO, Zhang L. Effects of sex differences in the phatmacokineics of drugs and their impact on the safety of medicines in women. In: Harrison-Woolrych M, editor. Medicines for women. Cham: Adis; 2015. https://doi.org/10.1007/978-3-319-12406-3_2.
Franconi F, Campesi I. Pharmacogenomics, pharmacogenetics and pharmacodynamics: interaction with biological fifferences between men and women. Br J Pharmacol. 2014;171:580–94.
Spina E, de Leon J. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2014;10:721–46.
Smith S. Gender differences in antipsychotic prescribing. Int Rev Psychiatry. 2010;22:472–84.
Wils RS, Gotfredsen DR, Hjorthøj C, Austin SF, Albert N, Secher RG, et al. Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis. Schizophr Res. 2017;182:42–8.
Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull. 2009;35:937–48.
Young SL, Taylor M, Lawrie SM. “First do no harm.” a systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol. 2015;29:353–62.
D'Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, et al. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. Fundam Clin Pharmacol. 2014;28:342–8.
Holm L, Ekman E, Jorsäter Blomgren K. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2017;26:335–43.
Seeman MV. Antipsychotics and physical attractiveness. Clin Schizophr Relat Psychoses. 2011;5:142–6.
Haack S, Seeringer A, Thurmann PA, Becker T, Kirchheiner J. Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics. 2009;10:1511–26.
Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand. 2013;127:12–22.
Seeman MV. Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatr Scand. 2012;125:363–71.
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015;125:1224–35.
Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol. 2015;116:315–20.
Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, et al. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand. 2015;132:S1–S28.
Kulkarni J, Storch A, Baraniuk A, Gilbert H, Gavrilidis E, Worsley R. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16:1335–45.
Rabinowitz J, Werbeloff N, Caers I, Mandel FS, Stauffer V, Ménard F, et al. Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials. J Clin Psychiatry. 2014;75:e308–e16.
Falkenburg J, Tracy DK. Sex and schizophrenia: a review of gender differences. Psychosis. 2014;6:61–9.
da Silva TL, Ravindran AV. Contribution of sex hormones to gender differences in schizophrenia: a review. Asian J Psychiatr. 2015;18:2–14.
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treat. 2012;2012:916198.
Remberk B, Bażyńska AK, Krempa-Kowalewska A, Rybakowski F. Adolescent insanity revisited: course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study. Compr Psychiatry. 2014;55:1174–81.
Juola P, Miettunen J, Veijola J, Isohanni M, Jääskeläinen E. Predictors of short–and long-term clinical outcome in schizophrenic psychosis–the Northern Finland 1966 Birth Cohort study. Eur Psychiatry. 2013;28:263–8.
Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296–306.
Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F. Gender differences in remission and recovery of schizophrenic and schizoaffective patients. Preliminary results of a prospective court study. Schizophr Res Treat. 2012;2012:576369.
Shibre T, Medhin G, Alem A, Kebede D, Teferra S, Jacobsson L, et al. Long-term clinical course and outcome of schizophrenia in rural Ethiopia: 10-year follow-up of a population-based cohort. Schizophr Res. 2015;161:414–20.
Carbon M. Clinical predictors of therapeutic response to antipsychotics in schizophrenia. Dialogues Clin Neurosci. 2014;16:505–24.